ArticleApplied health economics and health policy2025

Onasemnogene Abeparvovec Gene Therapy and Risdiplam for the Treatment of Spinal Muscular Atrophy in Thailand: A Cost-Utility Analysis.

Sarayuth Khuntha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.